On the contrary, treatment with hPDLSCs-CM or hPDLSCs-EMVs derived from MS patients [Fig. 8C] and donors [Fig. 8F] significantly prevented the EAE-induced cleaved caspase 3 expression. This evidence concerns the gene CASP3 and myeloid sarcoma.